by MM360 Staff | Jun 9, 2025 | Uncategorized
Source: CureToday articles Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship. Read More
by MM360 Staff | Jun 9, 2025 | Myeloma News
Source: Pharmacy Times articles Cilta-cel shows promise as a CAR T-cell therapy, offering long-term remission for relapsed/refractory multiple myeloma patients without maintenance treatment. Read More
by MM360 Staff | Jun 9, 2025 | Uncategorized
Source: CureToday articles Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among young women with cancer. Read More
by MM360 Staff | Jun 6, 2025 | Myeloma News
Source: Pharmacy Times articles Panelists discuss how evolving treatment pathways at Emory Healthcare, including earlier use of emerging therapies and off-label combination treatments, are shaping the management of chronic graft-vs-host disease (cGVHD), with an...
by MM360 Staff | Jun 6, 2025 | Publications
Clin Lymphoma Myeloma Leuk. 2025 May 14:S2152-2650(25)00159-4. doi: 10.1016/j.clml.2025.05.007. Online ahead of print. ABSTRACT BACKGROUND: The standard treatment for newly diagnosed, transplant-eligible multiple myeloma (NDMM) patients typically involves triplet...
